EcoDrugPlus

Ensembl ID : WBGene00227358
Gene Symbol: WBGENE00227358
4 External references
310 Possible Orthologues:

Ensembl ID : WBGene00227404
Gene Symbol: WBGENE00227404
5 External references
192 Possible Orthologues:

Ensembl ID : WBGene00227420
Gene Symbol: WBGENE00227420
6 External references
396 Possible Orthologues:

Ensembl ID : WBGene00227428
Gene Symbol: WBGENE00227428
5 External references
1192 Possible Orthologues:

Ensembl ID : WBGene00227482
Gene Symbol: WBGENE00227482
6 External references
52 Possible Orthologues:

Ensembl ID : WBGene00227487
Gene Symbol: WBGENE00227487
4 External references
58 Possible Orthologues:

Ensembl ID : WBGene00227498
Gene Symbol: WBGENE00227498
6 External references
78 Possible Orthologues:

Ensembl ID : WBGene00227538
Gene Symbol: WBGENE00227538
6 External references
85 Possible Orthologues:

Ensembl ID : WBGene00227541
Gene Symbol: WBGENE00227541
6 External references
67 Possible Orthologues:

Ensembl ID : WBGene00227544
Gene Symbol: WBGENE00227544
6 External references
75 Possible Orthologues:

Ensembl ID : WBGene00227604
Gene Symbol: WBGENE00227604
4 External references
729 Possible Orthologues:

Ensembl ID : WBGene00227642
Gene Symbol: WBGENE00227642
4 External references
329 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).